| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. (LCTX) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. LCTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $350.1K | - | |
| 10% | 75.0K | $102.8K | - | |
| Dir | 75.0K | $102.8K | - | |
| Dir | 75.0K | $102.8K | - | |
| Dir | 75.0K | $102.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Culley Brian M56 | President And CEO | Buy | 15,000 | $1.63 | $24,375.00 | +6.2% | - | - | |
| Jan 27, 2025 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 7,894,737 | $0.76 | $6,000,000.12 | +8.7% | -25.2% | +165.0% | |
| Nov 26, 2024 | Howe Jill Ann | Chief Financial Officer | Buy | 15,000 | $0.59 | $8,850.00 | +142.9% | +9.6% | +182.6% | |
| Nov 26, 2024 | Samuel George A. III | General Counsel | Buy | 15,000 | $0.60 | $9,000.00 | +208.8% | +9.6% | +182.6% | |
| Nov 22, 2024 | Mulroy Michael H. | Director | Buy | 40,000 | $0.57 | $22,640.00 | +15.5% | +37.6% | +245.3% | |
| Nov 21, 2024 | Culley Brian M56 | President And CEO | Buy | 40,000 | $0.60 | $24,000.00 | +25.8% | +19.8% | +190.0% | |
| Aug 16, 2024 | Howe Jill Ann | Chief Financial Officer | Buy | 10,500 | $0.89 | $9,345.00 | New | +2.9% | +39.5% | |
| May 24, 2024 | Culley Brian M56 | President And CEO | Buy | 10,000 | $1.05 | $10,500.00 | +6.9% | -15.0% | -35.0% | |
| Feb 8, 2024 | Bailey Don M | Director | Buy | 96,155 | $1.04 | $100,001.20 | +153.5% | +7.4% | -37.9% | |
| Feb 6, 2024 | Broadwood Partners, L.P.60 | Director, 10% Owner | Buy | 6,730,770 | $1.04 | $7,000,000.80 | +8.8% | +17.1% | -36.0% |